
    
      This study is designed as a double-blinded, randomized, cross-over trial (RCT). This part of
      the study takes 12 weeks (6 weeks of active treatment and 6 weeks of non-active treatment)
      and is followed by a wash-out period of 6 weeks. An uncontrolled,open phase starts after week
      18, where patients are followed one year after inclusion.

      30 participants with spasticity due to Stroke and Cerebral Palsy will be included.

      Two centers are recruiting participants and are collecting data.

      Outcome measures are chosen to reflect the different dimensions in the International
      Classification of Functioning, Disability and Health (ICF) and patient reported outcome
      measures (PROM).
    
  